X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203640
https://www.fiercepharma.com/pharma/novartis-signs-4-companies-provide-generic-versions-leukemia-drug-tasigna-poor-countries#:~:text=Generics%20to%20Novartis'%20leukemia%20drug,countries%20under%204%20MPP%20licenses&text=More%20than%20a%20year%20ago,treatments%20often%20are%20non%2Dexistent.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/aurobindo-pharma-arm-signs-pact-with-medicines-patent-pool-to-develop-anti-cancer-drug/articleshow/101211337.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
https://www.indianpharmapost.com/news/eugia-pharma-signs-voluntary-license-with-medicines-patent-pool-to-develop-generic-version-of-nilotinib-capsules-14315
https://endpts.com/mpp-signs-on-four-generics-makers-to-make-novartis-tasigna-more-accessible/
https://www.ndtv.com/world-news/novartis-pharma-signs-worlds-first-licensing-deal-for-cancer-drug-3448544
https://endpts.com/novartis-signs-landmark-licensing-deal-to-expand-access-to-patented-cancer-drug/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203640
https://scrip.pharmaintelligence.informa.com/SC143031/Novartis-Blocks-Suns-Nilotinib-Plans-In-India
http://www.pharmafile.com/news/550019/leukaemia-drug-nilotinib-shows-promise-against-alzheimer-s-small-clinical-study
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-tasigna-22068-nilotinib-capsules-50-mg-1573107456.pdf
https://www.fiercebiotech.com/research/new-evidence-shows-link-between-parkinson-s-disease-and-gut
https://www.fiercebiotech.com/research/how-novartis-cancer-drug-tasigna-works-parkinson-s-disease-patients
https://www.nbcnews.com/business/business-news/defying-trump-drugmakers-hike-prescription-drug-prices-2019-n953756?cid=public-rss_20190102
https://www.fiercepharma.com/pharma-asia/big-pharma-s-cancer-drugs-take-50-plus-discount-for-china-s-insurance-scheme
https://www.ema.europa.eu/documents/procedural-steps-after/iclusig-epar-procedural-steps-taken-scientific-information-after-authorisation_en-0.pdf
https://www.ema.europa.eu/documents/scientific-conclusion/iclusig-h-c-psusa-00010128-201712-epar-scientific-conclusions-grounds-variation-terms-marketing_en.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-16-2018-1526446624.pdf
https://www.biospace.com/article/lawsuits-allege-safety-concern-over-novartis-cml-drug-tasigna/
http://www.pharmatimes.com/news/tasigna_cleared_for_use_in_children_with_rare_leukemia_1229023
https://www.prnewswire.com/news-releases/novartis-drug-tasigna-approved-by-fda-to-treat-children-with-rare-form-of-leukemia-300618326.html
http://www.pmlive.com/pharma_news/fdas_year-end_approvals_take_annual_tally_to_46_1215003
http://www.pharmatimes.com/news/cml_patients_in_england_win_access_to_incytes_iclusig_1192128
http://www.nasdaq.com/article/novartis-announces-new-data-from-tasigna-enestop-tfr-20161205-01184
http://www.fiercepharma.com/pharma/under-drug-cost-attack-big-pharma-ceos-raise-value-based-pricing-flag
http://www.fiercebiotech.com/research/novartis-cancer-drug-to-be-tested-for-parkinson-s-disease
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2016/58222a-eng.php
http://twofourinsight.com/health-canadarequires-warning-gleevec-labeling-brand-generics/
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2016/58222a-eng.php
http://www.fiercepharma.com/pharma/new-novartis-meds-help-relieve-gleevec-generics-pain
http://www.fiercepharma.com/story/do-rebates-really-take-big-chunk-out-rising-drug-prices-not-necessarily-wap/2016-03-21
http://www.fiercepharma.com/story/novartis-braces-multibillion-dollar-generics-hit-gleevec-copies-launch/2016-02-01
http://www.pmlive.com/pharma_news/novartis_still_hungry_after_absorbing_gsk_oncology_718539
http://www.fiercepharma.com/story/gsk-deals-done-now-novartis-has-deliver-cancer-growth-pledge/2015-03-02
http://www.fiercepharma.com/story/novartis-faces-suspension-japan-after-series-trial-data-scandals/2015-02-03
Market Place
Share 
